Administration of Slow-Release Synthetic Prostacyclin Agonist Promoted Angiogenesis and Skeletal Muscle Regeneration for Limb Ischemia

Gene or cell therapy is currently not fully efficacious for arteriosclerosis obliterans (ASO). In this study, we determined whether YS-1402, a slow-release synthetic prostacyclin agonist, promoted neovascularization and skeletal muscle regeneration in a mouse model of critical limb ischemia (CLI). W...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Mol Ther Methods Clin Dev
Hoofdauteurs: Nakagawa, Takaya, Miyagawa, Shigeru, Shibuya, Takashi, Sakai, Yoshiki, Harada, Akima, Watanabe, Kenichi, Sawa, Yoshiki
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Gene & Cell Therapy 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7321796/
https://ncbi.nlm.nih.gov/pubmed/32637444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2020.05.022
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items